From Name

From Email

To Name

To Email

Message

BTK inhibitors, other blood cancer drugs are being tapped for COVID-19

from Pharmacy Practice News

BTK inhibitors, other blood cancer drugs are being tapped for COVID-19 Pharmacy Practice News The Bruton tyrosine kinase inhibitor acalabrutinib demonstrated benefit in a small uncontrolled case series of hospitalized patients with severe COVID-19, reducing measures of inflammation and improving oxygenation. The results support the idea that BTK inhibitors might effectively combat the hyperimmune reaction, or cytokine storm, that occurs in patients with severe COVID-19 and have led to larger confirmatory controlled trials. READ MORE

more